Oral contraceptive use and increased plasma concentration of C-reactive protein

Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled Trial

2002 • 15,184 citations

Randomized Trial of Estrogen Plus Progestin for Secondary Prevention of Coronary Heart Disease in Postmenopausal Women

1998 • 6,250 citations

Comparison of C-Reactive Protein and Low-Density Lipoprotein Cholesterol Levels in the Prediction of First Cardiovascular Events

2002 • 3,483 citations

Association of Fibrinogen, C-reactive Protein, Albumin, or Leukocyte Count With Coronary Heart Disease

1998 • 2,035 citations

C-Reactive Protein, a Sensitive Marker of Inflammation, Predicts Future Risk of Coronary Heart Disease in Initially Healthy Middle-Aged Men

1999 • 1,952 citations

Prospective Study of C-Reactive Protein and the Risk of Future Cardiovascular Events Among Apparently Healthy Women

1998 • 1,668 citations

Relation of C-Reactive Protein and Coronary Heart Disease in the MRFIT Nested Case-Control Study

1996 • 1,106 citations

Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation

1994 • 1,065 citations

C-reactive protein induces human peripheral blood monocytes to synthesize tissue factor

1993 • 809 citations

Effect of Postmenopausal Hormones on Inflammation-Sensitive Proteins

1999 • 679 citations

Oral Contraceptives and the Risk of Venous Thrombosis

2001 • 595 citations

Evaluation of Four Automated High-Sensitivity C-Reactive Protein Methods: Implications for Clinical and Epidemiological Applications

2000 • 593 citations

Hormone Replacement Therapy and Increased Plasma Concentration of C-Reactive Protein

1999 • 455 citations

Ischemic Stroke Risk With Oral Contraceptives

2000 • 397 citations

Stroke in Users of Low-Dose Oral Contraceptives

1996 • 335 citations

The Effects of Hormone Replacement Therapy and Raloxifene on C-Reactive Protein and Homocysteine in Healthy Postmenopausal Women: A Randomized, Controlled Trial1

2000 • 334 citations

Ischaemic stroke and combined oral contraceptives: results of an international, multicentre, case-control study

1996 • 323 citations

Low-dose oral contraceptives and acquired resistance to activated protein C: a randomised cross-over study

1999 • 270 citations

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the Womenʼs Health Initiative randomized controlled trial

2003 • 264 citations

Acute myocardial infarction and combined oral contraceptives: results of an international multicentre case-control study

1997 • 253 citations

Oral Contraceptives and the Risk of Myocardial Infarction

2002 • 240 citations

A Randomized Cross-over Study on the Effects of Levonorgestrel- and Desogestrel-containing Oral Contraceptives on the Anticoagulant Pathways

2000 • 213 citations

Contraceptivos orales y riesgo de infarto de miocardio

2001 • 193 citations

Haemorrhagic stroke, overall stroke risk, and combined oral contraceptives: results of an international, multicentre, case-control study

1996 • 174 citations

The use of oral contraceptives and the occurrence of acute myocardial infarction in young women

1997 • 171 citations

Third generation oral contraceptives and risk of myocardial infarction: an international case-control study

1996 • 163 citations

Increased C-reactive Protein Levels during Short-term Hormone Replacement Therapy in Healthy Postmenopausal Women

1999 • 147 citations

The Effects of Hormone Replacement Therapy and Raloxifene on C-Reactive Protein and Homocysteine in Healthy Postmenopausal Women: A Randomized, Controlled Trial

2000 • 141 citations

Menstrual cycle-associated changes in blood levels of interleukin-6, α1 acid glycoprotein, and C-reactive protein

1997 • 117 citations

Oral Contraceptive Use and Hormone Replacement Therapy Are Associated With Microalbuminuria

2001 • 107 citations

Haemorrhagic stroke, overall stroke risk, and combined oral contraceptives: results of an international, multicentre, case-control study. WHO Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception.

1996 • 105 citations

Low-Dose Oral Contraceptive Use and the Risk of Myocardial Infarction

2001 • 102 citations

Myocardial infarction in users of low-dose oral contraceptives

1996 • 94 citations

Haemorrhagic stroke, overall stroke risk, and combined oral contraceptives: Results of an international, multicentre, case‐control study

1997 • 90 citations

Effects of Soy Intake on Sex Hormone Metabolism in Premenopausal Women

1999 • 77 citations

Oral Contraceptives: Current Status

2001 • 73 citations

Modulation of IL-6 Production during the Menstrual Cycle in Vivo and in Vitro

2000 • 62 citations

Plasma lipids and desogestrel and ethinyl estradiol: a meta-analysis

1996 • 62 citations

Myocardial infarction and third generation oral contraceptives: aggregation of recent studies

2002 • 53 citations

Effect of two oral contraceptives containing ethinyl estradiol and gestodene or norgestimate on different lipid and lipoprotein parameters

1998 • 42 citations

C-reactive protein in pregnancy and contraception

1971 • 29 citations

The Effect of the Menstrual Cycle and of Ethinylestradiol on Nitric Oxide, Endothelin-1 and Homocysteine Plasma Levels

2000 • 21 citations

Elevated Plasma Fibrinogen and Increased Fibrin Turnover among Healthy Women who both Smoke and Use Low-dose Oral Contraceptives

1999 • 20 citations

Plasma soluble tumor necrosis factor-alpha receptors circulate in proportion to leptin levels during the menstrual cycle in lean but not in obese women

2000 • 19 citations

Oral contraceptive use is associated with increased cardiovascular reactivity in nonsmokers

2001 • 12 citations

Oral Contraceptives Highlight the Genotype-Specific Association Between Serum Phospholipids and Activated Factor VII

1999 • 5 citations